An Open-label, Safety and Tolerability Trial of Aripiprazole IM Depot Treatment Initiation in Adult Subjects With Schizophrenia Stabilized on Atypical Oral Antipsychotics Other Than Aripiprazole.
Phase of Trial: Phase I
Latest Information Update: 31 Oct 2014
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 26 Apr 2012 Actual end date (April 2012) added as reported by ClinicalTrials.gov.
- 26 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Mar 2012 New trial record